“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...

Why did “ Biotech is in a dark place ” resonate with so many of you? Because it’s true! Collectively, we’re all frustrated ...

An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Pfizer will end global development of its bleeding disorder gene therapy, Beqvez, the Nikkei reported on Thursday.

Biologists converted gut bacteria into miniature protein factories that manufacture and release a sustained flow of targeted proteins inside the lower intestines. This technique solves one of the ...

Researchers have identified a gene therapy that could prevent life-threatening arrhythmias by restoring the heart’s ...

The University of Sydney's zwitterionic coating research aims to enhance the lifespan of medical implants by preventing blood ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

Shares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...

VIXERAN biostimulant enables farmers to optimize nitrogen fertilizer use and transition to more sustainable on-farm practices ...